Last Updated: August 8, 2026

Laurus Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LAURUS

LAURUS has twenty-one approved drugs.

There are eight tentative approvals on LAURUS drugs.

Summary for Laurus

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	21
Patent Litigation for Laurus:	See patent lawsuits for Laurus

Drugs and US Patents for Laurus

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Laurus	SACUBITRIL AND VALSARTAN	sacubitril; valsartan	TABLET;ORAL	213676-002	May 28, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	214513-001	Jan 22, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	209882-002	Aug 27, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	MACITENTAN	macitentan	TABLET;ORAL	211120-001	Nov 5, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE	efavirenz; emtricitabine; tenofovir disoproxil fumarate	TABLET;ORAL	213541-001	Dec 22, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	209882-001	Aug 27, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Laurus	FLUCYTOSINE	flucytosine	CAPSULE;ORAL	218005-002	Jul 23, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Laurus

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.